Stress Cardiomyopathy in COVID-19 Disease
- PMID: 32523926
- PMCID: PMC7279910
- DOI: 10.12890/2020_001718
Stress Cardiomyopathy in COVID-19 Disease
Abstract
Patients affected by COVID-19 pneumonia may develop stress cardiomyopathy, also known as Takotsubo syndrome (TTS), at different stages during the disease and with different degrees of left ventricular dysfunction. We describe three cases of TTS in COVID-19-positive patients with different clinical presentations and outcomes. One of them died, while in the other two coronary angiography confirmed the diagnosis but was postponed until after pneumonia resolution because of the risk of virus spread.
Learning points: An association between COVID-19 and cardiac involvement is highlighted.The incidence of Takotsubo syndrome has increased during this pandemic, possibly because it is caused by acute stress.
Keywords: COVID-19; Takotsubo syndrome; cardiomyopathy.
© EFIM 2020.
Conflict of interest statement
Conflicts of Interests: The Authors declare that there are no competing interests.
Figures
References
-
- Reeder GS, Prasad A. Clinical manifestations and diagnosis of stress (takotsubo) cardiomyopathy. [accessed 14 May 2020]. Retrieved from https://www.uptodate.com.
LinkOut - more resources
Full Text Sources